Form 4: Clorox Director Stephanie Plaines Reports Acquisition of Deferred Stock Units

Stephanie Plaines, a director of Clorox, reported the acquisition of deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.

Summary

• Stephanie Plaines, a director at Clorox, filed a Form 4 detailing changes in beneficial ownership.
• On May 10, 2024, Ms. Plaines acquired 25.7305 deferred stock units through dividend reinvestment.
• On June 28, 2024, she acquired 192.35 deferred stock units in lieu of quarterly director's fees.
• These deferred stock units will be settled in Clorox stock upon her retirement or termination of service as a director.
• Following these transactions, Ms. Plaines beneficially owns 3,291.8084 deferred stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard director compensation practices and alignment of interests with shareholders.

Positives

• The acquisition of deferred stock units aligns the director's interests with those of the shareholders.
• Dividend reinvestment indicates confidence in the company's future performance.
• Accepting stock units in lieu of fees demonstrates a commitment to the company's long-term success.

Future Outlook

The deferred stock units will be settled 100% in Clorox stock upon the director's retirement or termination of service.

Industry Context

Directors often receive stock-based compensation to align their interests with shareholders, a common practice in corporate governance.

Stakeholder Impact

• The acquisition of deferred stock units aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.

Key Dates